Cargando…
Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancer
BACKGROUND: Gut tryptophan (Trp) metabolites are produced by microbiota and/or host metabolism. Some of them have been proven to promote or inhibit colorectal cancer (CRC) in vitro and animal models. We hypothesized that there is an alteration of gut Trp metabolism mediated by microbiota and that it...
Autores principales: | Sun, Xi-Zhen, Zhao, Dong-Yan, Zhou, Yuan-Chen, Wang, Qian-Qian, Qin, Geng, Yao, Shu-Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723673/ https://www.ncbi.nlm.nih.gov/pubmed/33362375 http://dx.doi.org/10.3748/wjg.v26.i45.7173 |
Ejemplares similares
-
Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis
por: Yang, Zhen-Huan, et al.
Publicado: (2021) -
Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome
por: Zhang, Wen-Xue, et al.
Publicado: (2019) -
Leukocyte immunoglobulin-like receptor B2 overexpression as a promising therapeutic target and noninvasive screening biomarker for colorectal cancer
por: Wang, Qian-Qian, et al.
Publicado: (2023) -
Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer
por: Wang, Qian-Qian, et al.
Publicado: (2022) -
Fecal microbiota transplantation in patients with metabolic syndrome and obesity: A randomized controlled trial
por: da Ponte Neto, Alberto Machado, et al.
Publicado: (2023)